ASA Offers Recommendations for HHS National Action Plan for Adverse Drug Event Prevention

On October 4, ASA offered official recommendations to the U.S. Department of Health and Human Services (HHS) for further development and refinement of the Draft National Action Plan for Adverse Drug Event Prevention.  ASA’s recommendations centered on pain medicine and opioid use, development of quality measures related to adverse drug events (ADEs) and the use of the Perioperative Surgical Home to coordinate care.

The Action Plan is an effort by the federal government to seek stakeholder engagement about ADEs. The plan lists two key objectives:  to "identify common, clinically significant, preventable, and measureable" ADEs and to "align the efforts of federal health agencies to reduce patient harms from those specific ADEs nationally."

Review ASA's recommendations. Learn more about the HHS Draft National Action Plan for Adverse Drug Event Prevention.